Skip to main content

What the label lists and what reports show

Dienogest and estradiol side effects

Dienogest and estradiol's FDA label: “The most common adverse reactions (≥ 2%) in clinical trials for Natazia are headache (including migraines) 13%, breast pain 7%, menstrual disorders 7%, nausea/vomiting 6%, acne 4%, mood changes (3%) and increased weight 3%.” FAERS holds 316 reports naming it through July 30, 2026; the reaction reported most often, leaving out the conditions it is used for, product-use terms and outcomes, is metrorrhagia (35 reports).

  • No generic listed
  • Boxed warning

Check it at the source: the dienogest and estradiol FDA label on DailyMed (effective June 26, 2024, Bayer HealthCare Pharmaceuticals Inc.); the FDA FAERS public dashboard.

What does the patient leaflet say about side effects?

From the patient leaflet: What are the Common Side Effects of Birth Control Pills?

The most common side effects of birth control pills are: • Spotting or bleeding between menstrual periods • Nausea • Breast tenderness • Headache These side effects are usually mild and usually disappear with time. Less common side effects are: • Acne • Less sexual desire • Bloating or fluid retention • Blotchy darkening of the skin, especially on the face • High blood sugar, especially in women who already have diabetes • High fat levels in the blood • Depression, especially if you have had depression in the past. Call your healthcare provider immediately if you have any thoughts of harming yourself. • Problems tolerating contact lenses • Weight changes This is not a complete list of possible side effects. Talk to your healthcare provider if you develop any side effects that concern you. You may report side effects to the FDA at 1-800-FDA-1088. […]

Source: FDA drug label, Bayer HealthCare Pharmaceuticals Inc., effective June 26, 2024 (SPL set 02c91fba-9c47-43ef-ac78-e82369798834), via openFDA; the full label on DailyMed

What does the label list?

From the label: adverse reactions

The most common adverse reactions (≥ 2%) in clinical trials for Natazia are headache (including migraines) 13%, breast pain 7%, menstrual disorders 7%, nausea/vomiting 6%, acne 4%, mood changes (3%) and increased weight 3%.

From the label: adverse reactions, continued

The following serious adverse reactions with the use of COCs are discussed elsewhere in the labeling: • Serious cardiovascular events and stroke [see Boxed Warning and Warnings and Precautions ( 5.1 )] • Vascular events [see Warnings and Precautions ( 5.1 )] • Liver disease [see Warnings and Precautions ( 5.3 )] Adverse reactions commonly reported by COC users are: • Irregular uterine bleeding • Nausea • Breast tenderness • Headache The most common adverse reactions (≥ 2%) in clinical trials for Natazia are headache (including migraines) 13%, breast pain 7%, menstrual disorders 7%, nausea/vomiting 6%, acne 4%, mood changes (3%) and increased weight 3%. ( 6 ) To report SUSPECTED ADVERSE REACTIONS, contact Bayer HealthCare Pharmaceuticals Inc. at 1-888-842-2937 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. Contraception and Heavy Menstrual Bleeding Studies A total of 2,131 women, 18 to 54 years of age, who took at least one dose of Natazia were enrolled in four clinical phase 3 trials.

Source: FDA drug label, Bayer HealthCare Pharmaceuticals Inc., effective June 26, 2024 (SPL set 02c91fba-9c47-43ef-ac78-e82369798834), via openFDA; the full label on DailyMed

What do FAERS reports show?

316 reports list dienogest and estradiol among the medicines taken, each a report of something that happened, not proof the medicine caused it; 0 are coded as a death and 19 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is. Of the 16 reactions below, 5 are named by the same term (in US spelling) in the label's adverse reactions, warnings or patient leaflet; a reaction the label does not name may still be there under another word, and a report does not show that the medicine caused it.

The 25 most reported reactions

  • Metrorrhagia35
  • Drug Dose Omission (a use or a product term, not a reaction)34
  • Headache (named in the label)17
  • Vaginal Haemorrhage15
  • Off Label Use (a use or a product term, not a reaction)14
  • Menstruation Delayed12
  • Pregnancy On Oral Contraceptive12
  • Nausea (named in the label)11
  • Product Use Issue (a use or a product term, not a reaction)11
  • Amenorrhoea (named in the label)10
  • Inappropriate Schedule Of Drug Administration (a use or a product term, not a reaction)9
  • Product Use In Unapproved Indication (a use or a product term, not a reaction)9
  • Vomiting (named in the label)9
  • Abnormal Withdrawal Bleeding8
  • Menorrhagia8
  • No Adverse Event (a use or a product term, not a reaction)8
  • Dizziness (named in the label)7
  • Drug Ineffective (a use or a product term, not a reaction)7
  • Extra Dose Administered7
  • Product Dose Omission Issue (a use or a product term, not a reaction)7
  • Inappropriate Schedule Of Product Administration (a use or a product term, not a reaction)6
  • Anaemia5
  • Depression5
  • Dyspnoea5
  • Fatigue5

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; reactions as MedDRA preferred terms

What next?

Dienogest and estradiol: the full record
label, generics, price, shortages, recalls
Side effects hub
the most reported medicines and reactions